Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity (JCI insight, 2018)

(untitled) - Liu, K; Li, D; Hao, G; McCaffary, D; Neely, O; Woodward, L; Ioannides, D; Lu, C; Brescia, M; Zaccolo, M; Tandri, H; Ajijola, O; et al.